Gujarat Themis Biosyn Ltd.
NSE: GUJTHEM BSE: GUJTHEM
Prev Close
283.65
Open Price
289
Volume
64,137
Today Low / High
283.5 / 305
52 WK Low / High
222.05 / 479
Range
286 - 317
Prev Close
282.25
Open Price
282.25
Volume
6,895
Today Low / High
282.25 / 304.8
52 WK Low / High
221.7 / 479.45
Range
284 - 314
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 301.45 (target range: 286 - 317), reflecting a change of 17.8 (6.27534%). On the BSE, it is listed at 299.3 (target range: 284 - 314), showing a change of 17.05 (6.04074%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Gujarat Themis Biosyn Ltd. Graph
Gujarat Themis Biosyn Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Gujarat Themis Biosyn Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 301.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 299.30 | 302.29 | 272.06 - 332.52 |
| 305.29 | 244.23 - 366.34 | ||
| 308.28 | 215.80 - 400.76 | ||
| Bearish Scenario | 299.30 | 296.31 | 266.68 - 325.94 |
| 293.31 | 234.65 - 351.98 | ||
| 290.32 | 203.22 - 377.42 |
Overview of Gujarat Themis Biosyn Ltd.
ISIN
INE942C01045
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
119,948
Market Cap
32,264,614,967
Last Dividend
0.67
Official Website
IPO Date
2025-02-25
DCF Diff
315.70
DCF
-20
Financial Ratios Every Investor Needs
Stock Dividend of GUJTHEM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-04 | September 04, 25 | 0.67 | 0.67 | 2025-09-05 | 2025-10-12 | |
| 2024-07-15 | July 15, 24 | 0.16667 | 0.16667 | 2024-07-15 | 2024-08-22 | |
| 2024-02-22 | February 22, 24 | 0.5 | 0.5 | 2024-02-22 | 2024-03-11 | |
| 2023-09-01 | September 01, 23 | 0.13333 | 0.13333 | 2023-09-01 | 2023-10-09 | |
| 2022-12-02 | December 02, 22 | 0.58667 | 0.58667 | 2022-12-02 | 2022-12-21 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 150.79 Cr | 31.88 Cr | 118.91 Cr | 0.7886 | 3.44 Cr | 2.35 Cr | 64.25 Cr | 48.77 Cr | 4.48 | 71.42 Cr | 0.3234 |
| 2024-03-31 | 169.81 Cr | 41.61 Cr | 128.20 Cr | 0.7550 | 3.90 Cr | 1.45 Cr | 75.55 Cr | 59.16 Cr | 5.43 | 83.54 Cr | 0.3484 |
| 2023-03-31 | 148.13 Cr | 30.78 Cr | 117.35 Cr | 0.7922 | 2.93 Cr | 1.44 Cr | 72.51 Cr | 57.97 Cr | 5.32 | 80.14 Cr | 0.3913 |
| 2022-03-31 | 114.19 Cr | 20.89 Cr | 93.30 Cr | 0.8170 | 0.45 Cr | 0.83 Cr | 56.57 Cr | 43.62 Cr | 4.00 | 62.00 Cr | 0.3820 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11.69 Cr | 301.31 Cr | 52.93 Cr | 248.3819 Cr | 30.47 Cr | 18.78 Cr | 5.05 Cr | 246.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 20.5597 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 91.0286 Cr | -111.8182 Cr | 26.0143 Cr | -25.1216 Cr | 5.2247 Cr | 0.1486 Cr | -1.3579 Cr | 65.5379 Cr | 29.8899 Cr | -0.0212 Cr | -1.7194 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 43.37 Cr | 23.67 Cr | 19.70 Cr | 0.4542 | 17.42 Cr | 12.46 Cr | 1.14 | 21.72 Cr | 0.2874 |
| 2025-09-30 | 42.35 Cr | 7.44 Cr | 34.91 Cr | 0.8244 | 17.98 Cr | 14.26 Cr | 1.31 | 21.76 Cr | 0.3368 |
| 2025-06-30 | 35.87 Cr | 8.00 Cr | 27.88 Cr | 0.7771 | 11.89 Cr | 9.06 Cr | 0.83 | 14.20 Cr | 0.2526 |
| 2025-03-31 | 37.72 Cr | 8.35 Cr | 29.37 Cr | 0.7787 | 15.59 Cr | 12.00 Cr | 0.00 | 17.26 Cr | 0.3180 |
| 2024-12-31 | 39.52 Cr | 8.86 Cr | 30.66 Cr | 0.7758 | 17.30 Cr | 12.97 Cr | 1.19 | 19.11 Cr | 0.3282 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 6.36 Cr | 4.03 Cr | 10.38 Cr | 35.15 Cr | 7.21 Cr | 54.80 Cr | 294.29 Cr | 376.67 Cr | 112.24 Cr |
| 2025-03-31 | 11.69 Cr | 1.85 Cr | 11.69 Cr | 31.45 Cr | 5.05 Cr | 51.97 Cr | 246.50 Cr | 301.31 Cr | 52.93 Cr |
| 2024-09-30 | 8.38 Cr | 9.73 Cr | 18.11 Cr | 28.57 Cr | 4.64 Cr | 52.25 Cr | 178.61 Cr | 248.15 Cr | 24.72 Cr |
| 2024-03-31 | 6.47 Cr | 7.66 Cr | 14.13 Cr | 27.59 Cr | 3.33 Cr | 47.56 Cr | 136.64 Cr | 221.11 Cr | 19.74 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
Gender: Not Specified
Year Born: 1975
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1954
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Gujarat Themis Biosyn Ltd.
The CEO is Sachin Dinesh Patel.
The current price is ₹296.10.
The range is ₹222.05-479.
The market capitalization is ₹3,226.46 crores.
The dividend yield is 0.23%.
The P/E ratio is 67.52.
The company operates in the Healthcare sector.
Overview of Gujarat Themis Biosyn Ltd. (ISIN: INE942C01045) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,226.46 crores and an average daily volume of 119,948 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.67.